# Method: Screening Donations & Cost Calculations | Breast…

> Source: https://breastcancer-charity.org/method/screening/
> How Breast Cancer Charity prices and describes £25 screening donations — overseas programme unit costs, statistical sources, and partner vetting.

📐 Methodology & Economics

## How We Define and Price "One Screening"

When Breast Cancer Charity states that **“£25 funds one complete breast cancer screening”**, we are describing a fully calculated programme unit cost in partner health settings in low- and middle-income regions (such as Pakistan, India, Kenya, and Nigeria).

This £25 unit cost is *not* an invoice for a UK private clinic mammogram (which typically costs £150–£350 privately in the UK), nor is it an NHS service charge (which is 100% free at point of care for eligible UK residents).

Instead, £25 covers the composite cost of delivering an end-to-end community screening intervention overseas:

- Clinical Breast Examination (CBE): Screening conducted by trained local female healthcare workers or nurses.
- Targeted Ultrasound Scan: Diagnostic imaging for women with suspicious lumps or dense tissue.
- Patient Health Education & TLC Guides: Vernacular educational pamphlets and self-examination materials.
- Mobile Outreach Unit Logistics: Vehicle fuel, transport, and equipment maintenance for remote rural screening camps.

## Detailed Unit Cost Breakdown Table

| Impact Tier | Cost | Intervention Details Included |
| --- | --- | --- |
| Single Screening | £25 | CBE exam + ultrasound triage + health awareness kit in outreach camps. |
| Diagnostic Biopsy Support | £75 | Core needle biopsy + pathology lab analysis + histology reporting for suspicious lesions. |
| Hormone Therapy Care Pack | £150 | 6-month supply of essential hormone therapy (tamoxifen/letrozole) + oncology nurse checkups. |

All unit cost data is published in machine-readable Open Knowledge Format (OKF) at [/data/screening-unit-cost-economics.csv](https://breastcancer-charity.org/data/screening-unit-cost-economics.csv).

## Data Sources & Global Survival Gap Verification

Our educational guides frequently highlight the stark global survival gap in breast cancer:

- High-Income Countries (UK/US/Europe): 5-year net survival rates exceed 85–90% due to routine mammography screening and early detection (Source: NHS Digital 2026, Cancer Research UK).
- Low- and Middle-Income Countries: 5-year survival drops to 40–65% primarily because 70% of women present at Stage 3 or Stage 4 when treatment is far more difficult (Source: WHO IARC Global Cancer Observatory 2024).

## Anti-Fabrication & Zero-Counter Rules

We adhere to strict zero-fabrication standards. We do *not* publish automated "lives saved" counter widgets or ticker animations that estimate impact without verified hospital receipts. Impact dashboards remain at exact audited figures until independent partner reports are verified.

Medical & Service Disclaimers

This methodology page explains donor unit cost calculations for overseas health programmes. It is not for UK readers seeking NHS mammograms or GP appointments.

[Editorial Policy →](https://breastcancer-charity.org/editorial-policy/) [Open Data Hub →](https://breastcancer-charity.org/open-data/) [Impact Transparency →](https://breastcancer-charity.org/your-impact/)

---
Breast Cancer Charity — an initiative of World Aid Network. Donate: https://breastcancer-charity.org/donate/